371 related articles for article (PubMed ID: 23789696)
1. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
Reiner CS; Merkle EM; Bashir MR; Walle NL; Nazeer HK; Gupta RT
AJR Am J Roentgenol; 2013 Jul; 201(1):W49-56. PubMed ID: 23789696
[TBL] [Abstract][Full Text] [Related]
2. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?
Ringe KI; Gupta RT; Brady CM; Massey CM; Hahn A; Galanski M; Merkle EM; Lotz J
Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758
[TBL] [Abstract][Full Text] [Related]
3. Gadoxetate Disodium-Enhanced MR Cholangiography for Evaluation of Biliary-Enteric Anastomoses: Added Value Beyond Conventional T2-Weighted Images.
Boraschi P; Donati F; Pacciardi F; Cervelli R; Gigoni R; Porcu L; Torri V
AJR Am J Roentgenol; 2019 Sep; 213(3):W123-W133. PubMed ID: 31063422
[No Abstract] [Full Text] [Related]
4. Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography: prospective comparison of patients with normal gallbladder function and acute cholecystitis.
Yacoub JH; Yousuf A; Agrawal G; Thomas S; Appelbaum DE; Oto A
Acta Radiol; 2015 Jul; 56(7):782-9. PubMed ID: 25009279
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of gadoxetate disodium-enhanced MR cholangiography in chronic cholestatic biliary disease.
Kühn JP; Spoerl M; Nassif A; Mester M; Weitschies W; Siegmund W; Hosten N; Mensel B
Clin Radiol; 2014 Oct; 69(10):1027-33. PubMed ID: 24957855
[TBL] [Abstract][Full Text] [Related]
6. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy?
Watanabe H; Kanematsu M; Goshima S; Yoshida M; Kawada H; Kondo H; Moriyama N
AJR Am J Roentgenol; 2012 Mar; 198(3):589-95. PubMed ID: 22357997
[TBL] [Abstract][Full Text] [Related]
7. Can biliary-cyst communication be predicted by Gd-EOB-DTPA-enhanced MR cholangiography before treatment for hepatic hydatid disease?
Kantarci M; Pirimoglu B; Ogul H; Bayraktutan U; Eren S; Aydinli B; Ozturk G; Karaca L
Clin Radiol; 2014 Jan; 69(1):52-8. PubMed ID: 24156798
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA for preoperative biliary mapping: correlation with intraoperative cholangiography.
Lee Y; Kim SY; Kim KW; Lee SS; Park SH; Byun JH; Lee MG
Acta Radiol; 2015 Jul; 56(7):773-81. PubMed ID: 25080516
[TBL] [Abstract][Full Text] [Related]
9. 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors.
Cai L; Yeh BM; Westphalen AC; Roberts J; Wang ZJ
Abdom Radiol (NY); 2017 Mar; 42(3):842-850. PubMed ID: 27714420
[TBL] [Abstract][Full Text] [Related]
10. High spatial resolution navigated 3D T1-weighted hepatobiliary MR cholangiography using Gd-EOB-DTPA for evaluation of biliary anatomy in living liver donors.
Lee JH; Kim B; Kim HJ; Kim BW; Wang HJ; Kim JK
Abdom Radiol (NY); 2018 Jul; 43(7):1703-1712. PubMed ID: 29450611
[TBL] [Abstract][Full Text] [Related]
11. The efficiency of Gd-EOB-DTPA-enhanced magnetic resonance cholangiography in living donor liver transplantation: a preliminary study.
Ogul H; Kantarci M; Pirimoglu B; Karaca L; Aydinli B; Okur A; Ozturk G; Kizrak Y
Clin Transplant; 2014 Mar; 28(3):354-60. PubMed ID: 24506817
[TBL] [Abstract][Full Text] [Related]
12. Functional MR cholangiography of the cystic duct and sphincter of Oddi using gadoxetate disodium: is a 30-minute delay long enough?
Corwin MT; Lamba R; McGahan JP
J Magn Reson Imaging; 2013 Apr; 37(4):993-8. PubMed ID: 23001618
[TBL] [Abstract][Full Text] [Related]
13. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
14. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
Bashir MR; Castelli P; Davenport MS; Larson D; Marin D; Hussain HK; Jaffe TA
Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310
[TBL] [Abstract][Full Text] [Related]
15. The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study.
Cho SH; Kang UR; Kim JD; Han YS; Choi DL
Eur J Radiol; 2011 Nov; 80(2):e195-200. PubMed ID: 21908121
[TBL] [Abstract][Full Text] [Related]
16. Determination of cystic duct patency using hepatobiliary MRI with gadoxetate disodium: is T1 precontrast imaging necessary?
Corwin MT; Karam AR; Baker SP; Kim YH
J Magn Reson Imaging; 2012 Mar; 35(3):601-6. PubMed ID: 22034256
[TBL] [Abstract][Full Text] [Related]
17. Added value of gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography for the diagnosis of post-transplant biliary complications.
Kinner S; Schubert TB; Said A; Mezrich JD; Reeder SB
Eur Radiol; 2017 Oct; 27(10):4415-4425. PubMed ID: 28409358
[TBL] [Abstract][Full Text] [Related]
18. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
Davenport MS; Caoili EM; Kaza RK; Hussain HK
Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
[TBL] [Abstract][Full Text] [Related]
19. An increased flip angle in late phase Gd-EOB-DTPA MRI shows improved performance in bile duct visualization compared to T2w-MRCP.
Stelter L; Freyhardt P; Grieser C; Walter T; Geisel D; Baur A; Seehofer D; Denecke T
Eur J Radiol; 2014 Oct; 83(10):1723-7. PubMed ID: 25022980
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment.
Carlos RC; Hussain HK; Song JH; Francis IR
AJR Am J Roentgenol; 2002 Jul; 179(1):87-92. PubMed ID: 12076911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
